UNSPSC 85881502: Nonimaging nuclear medicine assay of kidneys, ureters and bladder using iodine 125 (i-125)

This classification denotes the group of activities that yields an intervention or procedure of nonimaging nuclear medicine assay of kidneys, ureters and bladder using iodine 125 (i-125)nonimaging nuclear medicine assay of kidneys, ureters and bladder using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CT63HZZ

UNSPSC 85881502 Nonimaging nuclear medicine assay of kidneys, ureters and bladder using iodine 125 (I-125) is a Commodity code with no relevant recent state and local procurement activity in the source. The three opportunities posted between July and October 2026 tagged under this code involve diagnostic imaging PACS systems, special education contracted services, and temporary health professional staffing — none of which align with nuclear medicine assays or radioisotope-based diagnostic procedures. The mismatch between the code's nominal scope and actual recent solicitations suggests either broad misclassification at the source or minimal current demand for this specific nuclear medicine service among state and local buyers.

State and local procurement for nuclear medicine diagnostics, when it does occur, typically flows through health systems and public hospitals rather than appearing as standalone service solicitations. Without recent opportunities reflecting actual purchases of I-125 kidney, ureter, and bladder imaging services, there is insufficient market signal to recommend pursuit under this code at this time.